PHAR Form 6-K: Report of foreign private issuer, 2021

Pharming Group N.V. Form 6-K: Report of foreign private issuer

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

2021-10-28: Form 6-K; Period of report 2021-10-28; Description 6-K; Document pharminggroupfinancialresu.htm.
2021-10-22: Form 6-K; Period of report 2021-10-22; Description 6-K; Document analystcalldetailspr21oct21.htm.
2021-09-14: Form 6-K; Period of report 2021-09-14; Description 6-K; Document prcovidpreliminaryresults1.htm.
2021-08-09: Form 6-K/A; Period of report 2021-08-05; Description 6-K/A; Document h1pr2021duplicate.htm.

Filed	Form	Period of report	Description	Document
2021-10-28	6-K	2021-10-28	6-K	pharminggroupfinancialresu.htm
2021-10-22	6-K	2021-10-22	6-K	analystcalldetailspr21oct21.htm
2021-09-14	6-K	2021-09-14	6-K	prcovidpreliminaryresults1.htm
2021-08-09	6-K/A	2021-08-05	6-K/A	h1pr2021duplicate.htm
2021-08-05	6-K	2021-08-05	6-K	h1pr2021.htm
2021-07-20	6-K	2021-07-20	6-K	newbridge.htm
2021-07-01	6-K	2021-07-01	6-K	orchardprjuly1.htm
2021-06-24	6-K	2021-06-23	6-K	apdsenrolmentpr.htm
2021-06-21	6-K	2021-06-18	6-K	cmocsopressrelease.htm
2021-06-04	6-K	2021-06-04	6-K	spainreimbursementpr.htm
2021-06-01	6-K	2021-06-01	6-K	jefferies.htm
2021-05-19	6-K	2021-05-19	6-K	agmpressrelease.htm
2021-05-17	6-K	2021-05-17	6-K	haeday.htm
2021-05-13	6-K	2021-05-13	6-K	q121pr.htm
2021-04-22	6-K	2021-04-22	6-K	firstpaientakipr.htm
2021-04-07	6-K	2021-04-07	6-K	pharminggroupannouncesthef.htm
2021-04-07	6-K	2021-04-06	6-K	pharminggroupannouncesthep.htm
2021-03-23	6-K	2021-03-23	6-K	bodnominationspr23mar21.htm
2021-03-16	6-K	2021-03-16	6-K	oppenheimerhealthcareconfe.htm
2021-03-11	6-K	2021-03-11	6-K	biocapitalpressrelease.htm
2021-03-04	6-K	2020-12-31	6-K	a2020fullyearresultspr.htm
2021-03-02	6-K	2021-03-02	6-K	navigateapdspr1-masterfile.htm